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P U B L I S H E D B Y E L S E V I E R I N C .LettersDepression 1 Year After
CABG Is Predicted by
Acute Inﬂammatory
ResponsesTABLE 1 Interferon g And Elevated Depressive Symptoms
at 12 Months
Depressed
at 12 Months
Adjusted Odds Ratio
(95% CI)
p
Value
Interferon g
Low 4/45 (8.9) 1 [ref]
Medium 9/52 (17.3) 2.11 (0.55–8.03) 0.28
High 16/48 (33.3) 4.32 (1.21–17.96) 0.024
Pre-surgery depressive
symptoms
Low 11/107 (10.3) 1 [ref]
High 18/38 (47.4) 7.14 (2.84–17.96) <0.001
EuroSCORE, % 0.92 (0.77–1.09) 0.34
Values are n (%) unless otherwise indicated.
EuroSCORE ¼ European System for Cardiac Operative Risk Evaluation;
ref ¼ reference.Coronary artery bypass graft (CABG) is the treatment
of choice for patients with multivessel disease and
leads to reductions in long-term mortality, incidence
of myocardial infarction (MI), and revascularization.
Depressive symptoms occur in as many as 25%
of patients after CABG and predict cardiovascular
morbidity (1). The mechanisms underlying depressive
symptoms are poorly understood, but one possibility
is that they are stimulated through inﬂammatory
processes. Inﬂammatory cytokines may contribute to
depression, with both the innate and adaptive im-
mune responses being relevant (2). Cytokine levels
are markedly increased after CABG as part of the
systemic inﬂammatory response. We therefore hy-
pothesized that symptoms of depression measured
12 months after CABG would be predicted by the
magnitude of inﬂammatory responses in the days
immediately after surgery.
We investigated 145 patients who underwent elec-
tive CABG, measuring depressive symptoms 1 month
before and 12 months after surgery. Plasma
interleukin (IL)-6 and interferon gamma (IFN-g) con-
centrations 1 to 3 days after surgery were measured as
markers of innate and adaptive immune responses,
respectively. Depressive symptoms were measured
using the Beck Depression Inventory or the Patient
Health Questionnaire 9-item version, and standard
cutoffs were used to deﬁne signiﬁcant depressive
symptoms. Covariates included the European System
for Cardiac Operative Risk Evaluation (EuroSCORE), a
composite measure of mortality risk, and pre-surgery
depressive symptoms. We used logistic regression
to calculate the odds of depression in relation to me-
dium and large inﬂammatory responses, with the small
inﬂammatory response tertile as the reference group.
Signiﬁcant depressive symptoms were recorded
in 20% of patients 12 months after surgery and
were positively associated with the magnitude of
IFN-g responses to surgery. The mean concentra-
tions of IFN-g were 23.84  4.6, 37.81  4.7, and 58.68 7.5 pg/ml in the 3 tertiles. Compared with
the lowest tertile, the odds of depressive symptoms in
patients in the highest tertile were 4.32 (95% conﬁ-
dence interval: 1.21 to 17.96) after adjusting for
covariates (Table 1). The association also was signiﬁ-
cant when IFN-g was modeled as a continuous vari-
able rather than being categorized into tertiles, with
an adjusted odds ratio of 1.03 (95% conﬁdence inter-
val: 1.01 to 1.07, p ¼ 0.029) per pg/ml increase in
IFN-g. No association between depressive symptoms
and IL-6 after was observed.
These results are consistent with the notion that
high levels of inﬂammation after CABGmay contribute
to the development of later depressive symptoms. We
controlled for pre-surgical depressive symptoms and
cardiological status, factors potentially contributing to
depression, but the association with IFN-g remained
signiﬁcant. Further statistical adjustment for other
potential confounders was not possible due to the low
event count. Our studywas not powered to test clinical
cardiological outcomes, but the results suggest that
depressive symptoms and cardiac outcomes after
bypass surgery share a common biological basis. It is
notable that IL-6 was not related to subsequent
depressive symptoms. IL-6 and IFN-g represent
different immune pathways. Expression of IFN-g
suggests the involvement of tryptophan metabolism
because IFN-g induces indoleamine 2,3-dioxygenase,
which is responsible for the catabolism of trypto-
phan, leading to products such as kynurenine that
are directly implicated in depression, while also
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1711lowering the availability of serotonin in the brain
(3). Additionally, IFN-g is involved in cardiovascular
pathology (4). An earlier study of CABG patients
demonstrated that greater IFN-g concentration in
the 12 h after surgery predicted clinical cardiac
outcomes at 12 months (5). Increased IFN-g there-
fore provides a mechanistic link between depressive
symptoms and cardiac morbidity after CABG. These
observations are not only relevant to the mental
health of cardiac patients, but suggest that some of
the adverse cardiovascular effect of depression
may be due to inﬂammatory processes. Targeting
inﬂammatory processes may have an impact on
depressive symptoms as well as potentially re-
ducing cardiac morbidity.FIGURE 1 Scatter-Plot of Gini Coefﬁcient Versus
Log-Transformed IF for 129 Cardiovascular Journals
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(y-axis) Gini coefﬁcient of cardiovascular journals calculated
based on cumulative citations from 2010 to 2012 for papers
published in 2010. (x-axis) Log-transformed 2012 impact factor
(IF). Each dot represents an individual journal. The line of best ﬁtAssociation Between
Journal Citation
Distribution and
Impact Factor
A Novel Application of the Gini Coefﬁcient(trend line) is shown indicating the association between the Gini
coefﬁcient and the log-IF.It is unknown whether some cardiovascular journals
achieve high impact factors (IFs) due to citations fromthe entire spectrum of their papers or from the publi-
cation of a few highly-cited papers, such as clinical
practice guidelines. To address this question, we
quantiﬁed the variation in cardiovascular journals’
citation distributions and whether the variation was
associated with the IF. Uneven citation distributions
can be studied with techniques that assess inequality.
One such measure is the Gini coefﬁcient, which is uti-
lized to characterize inequality in income distribu-
tions. It has a range of 0 to 1, where a Gini coefﬁcient of
0 represents perfect equality, meaning, in this case,
that all papers have an equal number of citations (1).
We identiﬁed all journals from 2010 that primarily
published cardiovascular content (n ¼ 241) using
SCImago (Granada, Spain), a third-party provider that
categorizes journals into ﬁelds on the basis of journal
data obtained from the Scopus citation database. We
used Scopus because it is a larger citation database
than Thompson Reuters’ Web of Science, which pro-
vides the journal IF (2). We excluded journals
with <20 papers (n ¼ 54) and <20 citations (n ¼ 5) to
avoid the downward bias associated with small sam-
ples sizes with the Gini calculation (3). We then
excluded journals not indexed in Web of Science
(without a 2012 IF) (n ¼ 53) (4). Among included
journals, we assessed the total number of citable
documents (original articles and reviews [including
guidelines] in 2010; heretofore, we will refer to all of
these documents as “papers”) and the cumulative
citations from 2010 to 2012 for each paper.
For each journal, we ranked the journal’s papers by
the number of citations (from lowest to highest) and
